Loading...
Market
Will Pfizer's adjusted EPS exceed $1.10 in Q4 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Pfizer's official Q4 2024 earnings report
Story
Pfizer Raises Profit Forecast by $1.5B, Beats Earnings Amid Starboard Pressure
Oct 29, 2024, 11:02 AM
Pfizer Inc. reported better-than-expected third-quarter earnings on Tuesday, fueled by strong demand for its cancer drugs and COVID-19 treatment. The U.S. drugmaker raised its full-year profit forecast and increased its 2024 guidance by $1.5 billion, signaling confidence amid pressure from activist hedge fund Starboard Value to demonstrate a turnaround. Pfizer now expects core operating income growth in the high teens. Adjusted earnings per share were $1.06, surpassing analysts' estimates of $0.62. Revenue topped expectations at $17.7 billion versus the forecasted $14.92 billion. The positive results mark a significant moment for CEO Albert Bourla as the company faces scrutiny over its strategic direction.
View original story
Similar markets
$2.80 - $2.85 • 25%
$2.86 - $2.90 • 25%
$2.91 - $2.95 • 25%
$2.96 - $3.00 • 25%
Outperforms by more than 5% • 25%
Outperforms by 0% to 5% • 25%
Underperforms by 0% to 5% • 25%
Underperforms by more than 5% • 25%